Aug 2026
Minimizing time in culture: A prototypic autologous manufacturing workflow for monoclonal iPSC lines within seven weeks
A standardizable, automatable and time- efficient process for the derivation of monoclonal iPSC lines straight from skin including a comprehensive and cascaded ǪC strategy is developed, moving the field of autologous iPSC manufacturing one step further towards cost-efficient clinical implementation.
D. Haberhausen, Christian Wöhle, Constanze Raab et al.
· bioRxiv · 0 citations